Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Ionescu, Filip, Ajayi, Eloho, Leach, Aamia, Alsina, Melissa, Bejanyan, Nelli, Castaneda, Omar, Elmariah, Hany, Freeman, Ciara, Hansen, Doris K, Jain, Michael D, Khimani, Farhad, Lazaryan, Aleksandr, Liu, Hien, Locke, Frederick L., Mishra, Asmita, Nieder, Dr. Michael L., Ochoa, Leonel, Perez, Lia Elena, Pidala, Joseph A., Quilitz, Rod, Klinkova, Olga V, Baluch, Aliyah, Nishihori, Taiga, Faramand, Rawan G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023
Materias:
Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899535/
http://dx.doi.org/10.1016/S2666-6367(23)00506-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899535/
http://dx.doi.org/10.1016/S2666-6367(23)00506-7

Ejemplares similares